Faculty profile

Daniel Muruve

ResearcherMedicineUniversity of Calgary

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.

Daniel Muruve

Researcher

Medicine

Health Sciences

University of Calgary

Calgary, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
3 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 9 research grants (9 CIHR), most recently in 2023.
Supervisor on 1 trainee award (1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Inflammation Chronic Kidney Disease Kidney Disease Acute Kidney Injury Therapeutics Innate Immunity Cardiovascular Disease Clinical Trial

Latest papers

Efficacy of cilastatin sodium in a translational large animal crush syndrome model.
Communications medicine · 2026
Loss of endothelial CD2AP causes sex-dependent cerebrovascular dysfunction.
Neuron · 2025
Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19).
BMJ open · 2024 · senior author

All 11 publications

Latest funding

Prevention of Nephrotoxin-induced Acute Kidney Injury with Cilastatin (PONTIAC) Trial
CIHR · 2023 · Principal investigator
$20,000
Fluorescence Spectroscopy of Islet Amyloid Polypeptide to Better Understand Diabetic Kidney Disease Pathogenesis and Improve Diagnostic Testing
CIHR · 2022 · Supervisor
$105,000
A Multifaceted Function for Dipeptidase-1 in Kidney Injury
CIHR · 2022 · Nominated PI
$1,109,250

All 10 grants and awards

11 publications.

Efficacy of cilastatin sodium in a translational large animal crush syndrome model.

Munhall AC, Eiwaz MB, Hebert JF, Groat T, Andeen NK, Muruve D, Stewart IJ, Loss L, Buzzard L, Liu M, Pierre L, Tinoco-Garcia L, Durbin S, Beiling M, Minoza K, Garay JP, Schreiber MA, Hutchens MP

Communications medicine2026

DOI: 10.1038/s43856-026-01411-1 PMID: 41820509

Loss of endothelial CD2AP causes sex-dependent cerebrovascular dysfunction.

Vandal M, Institoris A, Reveret L, Korin B, Gunn C, Hirai S, Jiang Y, Lee S, Lee J, Bourassa P, Mishra RC, Peringod G, Arellano F, Belzil C, Tremblay C, Hashem M, Gorzo K, Elias E, Yao J, Meilandt B, Foreman O, Roose-Girma M, Shin S, Muruve D, Nicola W, Körbelin J, Dunn JF, Chen W, Park SK, Braun AP, Bennett DA, Gordon GRJ, Calon F, Shaw AS, Nguyen MD

Neuron2025

DOI: 10.1016/j.neuron.2025.01.006 PMID: 39892386

Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19).

Somayaji R, Luke DR, Lau A, Guner R, Tabak ŎF, Hepokoski M, Gardetto N, Conrad SA, Kumar SD, Ghosh K, Robbins SM, Senger DL, Sun D, Lim RKS, Liu J, Eser F, Karaali R, Tremblay A, Muruve D

BMJ open2024Senior author

DOI: 10.1136/bmjopen-2023-076142 PMID: 38490660

How Semantics Connotations May Influence Concerns About Donation of Biospecimens.

Page SA, Collisson BA, Godley J, Nguyen D, Metz L, Muruve D

Biopreservation and biobanking2021Senior author

DOI: 10.1089/bio.2020.0072 PMID: 33179960

Sociodemographic associations with abnormal estimated glomerular filtration rate (eGFR) in a large Canadian city: a cross-sectional observation study.

Ma I, Guo M, Muruve D, Benediktsson H, Naugler C

BMC nephrology2018

DOI: 10.1186/s12882-018-0991-5 PMID: 30092764

A peptide-based biological coating for enhanced corrosion resistance of titanium alloy biomaterials in chloride-containing fluids.

Muruve N, Feng Y, Platnich J, Hassett D, Irvin R, Muruve D, Cheng F

Journal of biomaterials applications2017

DOI: 10.1177/0885328217692949 PMID: 28274193

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.

Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, Bodria M, Caridi G, Wei C, Belingheri M, Ghio L, Merscher-Gomez S, Edefonti A, Pasini A, Montini G, Murtas C, Wang X, Muruve D, Vaglio A, Martorana D, Pani A, Scolari F, Reiser J, Ghiggeri GM

Kidney international2013

DOI: 10.1038/ki.2013.211 PMID: 23739238

NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis.

Hirota SA, Ng J, Lueng A, Khajah M, Parhar K, Li Y, Lam V, Potentier MS, Ng K, Bawa M, McCafferty DM, Rioux KP, Ghosh S, Xavier RJ, Colgan SP, Tschopp J, Muruve D, MacDonald JA, Beck PL

Inflammatory bowel diseases2011

DOI: 10.1002/ibd.21478 PMID: 20872834

Morphometric and biological characterization of biofilm in tunneled hemodialysis catheters.

Jones SM, Ravani P, Hemmelgarn BR, Muruve D, Macrae JM

American journal of kidney diseases : the official journal of the National Kidney Foundation2011

DOI: 10.1053/j.ajkd.2010.10.053 PMID: 21257245

The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination.

Thalappilly S, Feng X, Pastyryeva S, Suzuki K, Muruve D, Larocque D, Richard S, Truss M, von Deimling A, Riabowol K, Tallen G

PloS one2011

DOI: 10.1371/journal.pone.0021065 PMID: 21731648

Prevention of Nephrotoxin-induced Acute Kidney Injury with Cilastatin (PONTIAC) Trial

Principal investigatorCIHR2023Team Gr.:Intervention Trial in Inflam. for Chronic Condition - General Pool LOI

Principal investigators: James, Matthew T; Muruve, Daniel A; Pannu, Neesh I

Keywords: Cardiovascular Disease; Clinical Trial; Kidney Disease; Nephrotoxicity

$20,000

Fluorescence Spectroscopy of Islet Amyloid Polypeptide to Better Understand Diabetic Kidney Disease Pathogenesis and Improve Diagnostic Testing

SupervisorCIHR2022Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: Brandt, Paula J

Keywords: Biophysics; Diabetic Nephropathy; Fluorescence Spectroscopy; Renal Amyloidosis

$105,000

A Multifaceted Function for Dipeptidase-1 in Kidney Injury

Nominated PICIHR2022Project Grant

Principal investigators: Muruve, Daniel A

Keywords: Acute Kidney Injury; Chronic Kidney Disease; Inflammation; Kidney Repair; Macrophages; Therapeutics

$1,109,250

Therapeutic Targeting a Shared Inflammation Pathway in the Lung and Kidney

Nominated PICIHR2021Team Grant: Preparation to Trial: Inflammation for Chronic Conditions

Principal investigators: Muruve, Daniel A; Kubes, Paul; Senger, Donna L

Keywords: Chronic Kidney Disease; Chronic Lung Disease; Critical Illness; Inflammation; Therapeutics

$750,000

Renal Immune Surveillance in Kidney Injury and Disease

Nominated PICIHR2018Project Grant

Principal investigators: Muruve, Daniel A

Keywords: Acute Kidney Injury; Inflammation; Innate Immunity; Interstitial Nephritis; Kidney Disease; Mouse Models

$810,135

NOD-Like Receptors and Inflammasomes in Kidney Disease

Nominated PICIHR2013Operating Grant

Principal investigators: Muruve, Daniel A

Keywords: Biomarkers; Cell Signaling; Chronic Kidney Disease; Clinical Translation; Cytokines; Inflammation; Innate Immunity; Renal Fibrosis

$812,117

CRC Tier 2

Nominated PICIHR2013Canada Research Chairs - CIHR Funded - Tier 2

Principal investigators: Muruve, Daniel A

Keywords: Crc

$500,000

NanoBiotechnology: Applications in Human Disease

Nominated PICIHR2009Emerging Team Grant: Regenerative Medicine and Nanomedicine - LOI

Principal investigators: Muruve, Daniel A; Irvin, Randall T; Macdonald, Justin A

Keywords: Biosensors; Cancer; Inflammation; Nanotechnology; Peptide/Protein Chemistry; Stem Cells

CANADA RESEARCH CHAIRHOLDER / TITULAIRE DE CHAIRE DE RECHERCHE DU CANADA

Nominated PICIHR2008Canada Research Chairs - CIHR Funded - Tier 2

Principal investigators: Muruve, Daniel A

Keywords: Crc

$500,000

The Role of the Inflammasome in Renal Injury

Nominated PICIHR2008Operating Grant

Principal investigators: Muruve, Daniel A

Keywords: Cytokines; Inflammation; Innate Immune System; Kidney Disease; Kidney Failure; Renal Tubular Epithelium

$512,080

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Daniel Muruve

Research

Latest papers

Latest funding

Efficacy of cilastatin sodium in a translational large animal crush syndrome model.

Loss of endothelial CD2AP causes sex-dependent cerebrovascular dysfunction.

Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19).

How Semantics Connotations May Influence Concerns About Donation of Biospecimens.

Sociodemographic associations with abnormal estimated glomerular filtration rate (eGFR) in a large Canadian city: a cross-sectional observation study.

A peptide-based biological coating for enhanced corrosion resistance of titanium alloy biomaterials in chloride-containing fluids.

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.

NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis.

Morphometric and biological characterization of biofilm in tunneled hemodialysis catheters.

The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination.

Prevention of Nephrotoxin-induced Acute Kidney Injury with Cilastatin (PONTIAC) Trial

Fluorescence Spectroscopy of Islet Amyloid Polypeptide to Better Understand Diabetic Kidney Disease Pathogenesis and Improve Diagnostic Testing

A Multifaceted Function for Dipeptidase-1 in Kidney Injury

Therapeutic Targeting a Shared Inflammation Pathway in the Lung and Kidney

Renal Immune Surveillance in Kidney Injury and Disease

NOD-Like Receptors and Inflammasomes in Kidney Disease

CRC Tier 2

NanoBiotechnology: Applications in Human Disease

CANADA RESEARCH CHAIRHOLDER / TITULAIRE DE CHAIRE DE RECHERCHE DU CANADA

The Role of the Inflammasome in Renal Injury

Frequent collaborators

Pietro Ravani

Christopher Naugler

Ken Parhar

Wilten Nicola

Irene Ma

Ranjani Somayaji

Karl Riabowol

Jenny Godley